Back to MORGAN STANLEY MORGAN STANLEY

SRPTSRPT
8 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in SAREPTA THERAPEUTICS INC

MORGAN STANLEY holds 2.6M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $56.5M as of 2026-Q1. The position was increased (+35.8% shares). SRPT represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$56.5M

Current Shares

2.6M

Total Value Change

-$358M

Total Shares Change

-26,368

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.6M
+35.8%
$56.5M0.0%$15.87
38
2025-Q4
Decreased
1.9M
-1.8%
$41.2M0.0%$21.49
0
2025-Q3
Increased
1.9M
+31.0%
$37.5M0.0%$18.82
37
2025-Q2
Decreased
1.5M
-24.6%
$25.4M0.0%$17.11
0
2025-Q1
Increased
2M
+98.9%
$125.9M0.0%$70.41
49
2024-Q4
Increased
991,655
+4.0%
$120.6M0.0%$121.19
31
2024-Q3
Decreased
953,104
-63.7%
$119M0.0%$124.53
0
2024-Q2
New
2.6M
-
$414.5M0.0%$158.00
43

Other major holders of SRPT: BlackRock Finance, Inc., BlackRock, Inc., Capital Research Global Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used